Arcturus Therapeutics Holdings Inc [NASDAQ: ARCT] surged by $0.23 during the normal trading session on while it closed the day at $10.53.
Arcturus Therapeutics Holdings Inc stock has also gained 12.62% of its value over the past 7 days. However, ARCT stock has declined by -38.10% in the 3 months of the year. Over the past six months meanwhile, it has lost -49.79% and lost -37.95% year-on date.
The market cap for ARCT stock reached $285.57 million, with 27.00 million shares outstanding and 24.37 million shares in the current float. Compared to the average trading volume of 434.93K shares, ARCT reached a trading volume of 358078 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Arcturus Therapeutics Holdings Inc [ARCT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ARCT shares is $66.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ARCT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Arcturus Therapeutics Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 28, 2025. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Outperform. The new note on the price target was released on August 12, 2024, representing the official price target for Arcturus Therapeutics Holdings Inc stock. Previously, the target price had yet another raise to $90, while Canaccord Genuity analysts kept a Buy rating on ARCT stock.
The Average True Range (ATR) for Arcturus Therapeutics Holdings Inc is set at 0.95, with the Price to Sales ratio for ARCT stock in the period of the last 12 months amounting to 2.06. The Price to Book ratio for the last quarter was 1.18, with the Price to Cash per share for the same quarter was set at 10.77.
ARCT stock trade performance evaluation
Arcturus Therapeutics Holdings Inc [ARCT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 12.62. With this latest performance, ARCT shares dropped by -21.42% in over the last four-week period, additionally sinking by -49.79% over the last 6 months – not to mention a drop of -65.05% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ARCT stock in for the last two-week period is set at 43.15, with the RSI for the last a single of trading hit 49.04, and the three-weeks RSI is set at 41.14 for Arcturus Therapeutics Holdings Inc [ARCT]. The present Moving Average for the last 50 days of trading for this stock 13.62, while it was recorded at 10.26 for the last single week of trading, and 18.15 for the last 200 days.
Arcturus Therapeutics Holdings Inc [ARCT]: An insightful look at the core fundamentals
Arcturus Therapeutics Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.67 and a Current Ratio set at 4.67.
Earnings per share (EPS) analysis for Arcturus Therapeutics Holdings Inc [ARCT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ARCT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Arcturus Therapeutics Holdings Inc go to 38.83%.
Arcturus Therapeutics Holdings Inc [ARCT]: Institutional Ownership
There are presently around $92.67%, or 101.22%% of ARCT stock, in the hands of institutional investors. The top three institutional holders of ARCT stocks are: FEDERATED HERMES, INC. with ownership of 4.69 million shares, which is approximately 17.4067%. BLACKROCK INC., holding 2.65 million shares of the stock with an approximate value of $$64.52 million in ARCT stocks shares; and BLACKROCK INC., currently with $$47.85 million in ARCT stock with ownership which is approximately 7.2866%.
